Marksans Pharma Ltd

Around 51% comes from Pain Management, 11% comes from Cough & Cold, 8% comes from Cardiovascular System, 6% comes from Gastrointestinal, and the rest comes from Anti-Diabetic, AntiAllergic.

TARGET AND STOPLOSS IN CHART

Market Cap
₹ 4,176 Cr.

Current Price
₹ 92.2

High / Low
₹ 94.3 / 38.6

Stock P/E
15.8

Book Value
₹ 38.5

Dividend Yield
0.54 %

ROCE
22.5 %

ROE
18.6 %

Face Value
₹ 1.00

Promoter holding
43.8 %

EPS last year
₹ 5.88

EPS latest quarter
₹ 1.81

Debt
₹ 123 Cr.

Pledged percentage
0.00 %

Net CF
₹ 176 Cr.

Price to Cash Flow
17.6

Free Cash Flow
₹ 184 Cr.

Debt to equity
0.07

OPM last year
18.3 %

OPM 5Year
18.4 %

Reserves
₹ 1,700 Cr.

Price to book value
2.31

Int Coverage
38.0

PEG Ratio
0.31

Trade ist aktiv

Trade ist aktiv:

10 % up

Trade ist aktiv:

T2 DOne

Trade ist aktiv:

Target Done Trail SL